Marilyn Jenrette
Family Medicine · North Canton, OHNPI 1659365252
Payments from drug & device makers
Across 167 payments — averaging $16.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$444
- Novo Nordisk$431
- AbbVie$308
- Lilly USA, LLC$197
- Amgen$164
- GSK$149
- plus $1K from 20 others
What the payments were for
- Food & beverage$2,77499%
- Education$271%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 21 | $444 |
| Novo Nordisk | 27 | $431 |
| AbbVie | 22 | $308 |
| Lilly USA, LLC | 13 | $197 |
| Amgen | 4 | $164 |
| GSK | 10 | $149 |
| Amarin Pharma, Inc. | 9 | $132 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $129 |
| Merck | 7 | $103 |
| Boehringer Ingelheim | 7 | $98 |
| Pfizer | 5 | $92 |
| Biohaven Pharmaceutical Holding Company Ltd. | 5 | $85 |
| Novartis | 5 | $74 |
| Bayer | 4 | $73 |
| Astellas Pharma US Inc | 4 | $65 |
| Zyla Life Sciences, Inc. | 3 | $50 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $42 |
| Abbott | 2 | $35 |
| Genentech USA, Inc. | 1 | $20 |
| Exact Sciences | 1 | $20 |
| E.r. Squibb & Sons, L.L.C. | 1 | $20 |
| Eisai Inc. | 1 | $17 |
| VBI Vaccine (delaware) Inc. | 1 | $15 |
| Si-bone, Inc. | 1 | $14 |
| Sanofi Pasteur Inc. | 1 | $14 |
| AMAG Pharmaceuticals, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,802 in reported general payments places this provider in the 75th percentile of 3,983 family medicine providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TradjentaLinagliptin | 13 | $7,790 |
| Ezetimibe | 25 | $1,156 |
| Atorvastatin Calcium | 50 | $558 |
| Lisinopril | 72 | $526 |
| Rosuvastatin Calcium | 46 | $404 |
| Pravastatin Sodium | 30 | $389 |
| Omeprazole | 32 | $376 |
| Alendronate Sodium | 29 | $291 |
| Levothyroxine Sodium | 32 | $290 |
| Valsartan | 17 | $274 |
| Metformin Hcl | 27 | $234 |
| Olmesartan Medoxomil | 15 | $205 |
| Amlodipine Besylate | 40 | $198 |
| Metformin Hcl ErMetformin Hcl | 23 | $169 |
| Simvastatin | 31 | $148 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimTradjenta | $98 | $7,79013 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,983 family medicine providers in Ohio.
Other family medicine in North Canton
- Michael ButcherCincinnati$18.3M
- William RandallKettering$7.5M
- Paul NugentCincinnati$4.9M
- Steve ChoiDayton$4.8M
- Martin SchearDayton$2.2M
- Rajesh DavitCincinnati$2M
- Kwabena OtengSpringdale$2M
- Blaise GattoMoraine$1.8M
- Cathy GreiweColumbus$1.4M
- Brian BeesleyColumbus$1.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.